Importantly, selected DNR-up-regulated genes were also rapidly induced in three primary AML patient samples and one of them (NFKB2) was also rapidly upregulated in vivo during standard AML chemotherapy. This evidence concerns the gene NFKB2 and acute myeloid leukemia.